Adel L. Barsoum - Concepedia

Author

Adel L. Barsoum

Also Known As

A Barsoum, A L Barsoum, A. L. BARSOUM, A. L. Barsoum, A.L. Barsoum, ADEL L. BARSOUM, Adel Barsoum, Adel L Barsoum, Adel L. Barsoum

Publications

810

Citations

H-Index

Concepts

All Affiliations

University of South Alabama Asklepios Klinik St. Georg Christian-Albrechts-Universität zu Kiel Institute of Cancer Research Clinical Research Center Kiel

About

Adel L. Barsoum is an author at University of South Alabama specializing in immunology, medicine, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	13	275
2	Cell Biology	7	7	160
3	Natural Sciences	1	1	12
4	Biochemistry	1	1	12
5	Cellular Therapies	1	1	23

Adel L. Barsoum

Publications

708

Citations

H-Index

Page 1

	Year	Citations
Immunotherapy of metastatic renal cell carcinoma with tumor lysate-pulsed autologous dendritic cells. Lorenz Höltl, Claudia Zelle‐Rieser, Hubert Gander, PubMed	2002	234
Induction of cytotoxic T-cell responses against the oncofetal antigen-immature laminin receptor for the treatment of hematologic malignancies Sandra Siegel, Andreas Wagner, Dieter Kabelitz, Blood	2003	76
37 kiloDalton oncofetal antigen protein and immature laminin receptor protein are identical, universal T-cell inducing immunogens on primary rodent and human cancers. Joseph H. Coggin, Adel L. Barsoum, Jack Rohrer PubMed ImmunologyPathologyImmunologic MechanismAntigen ProcessingImmunotherapy	2000	38
Identification of HLA-A*0201-Presented T Cell Epitopes Derived from the Oncofetal Antigen-Immature Laminin Receptor Protein in Patients with Hematological Malignancies Sandra Siegel, Andreas Wagner, Birte Friedrichs, The Journal of Immunology HistocompatibilityImmunologyPathologyAntigen ProcessingImmunotherapeutics	2006	36
Human breast carcinoma patients develop clonable oncofetal antigen-specific effector and regulatory T lymphocytes. J W Rohrer, Adel L. Barsoum, Donna Lynn Dyess, PubMed Breast OncologyLymphocyte DevelopmentImmunologyPathologyImmunologic Mechanism	1999	33
IL-17 is a potent synergistic factor with GM-CSF in mice in stimulating myelopoiesis, dendritic cell expansion, proliferation, and functional enhancement Bainan Liu, Weihong Tan, Adel L. Barsoum, Experimental Hematology InflammationFunctional EnhancementCytokineAutoimmune DiseaseImmunology	2010	33
EXPRESSION AND IMMUNOGENICITY OF ONCOFETAL ANTIGEN-IMMATURE LAMININ RECEPTOR IN HUMAN RENAL CELL CARCINOMA Claudia Zelle‐Rieser, Adel L. Barsoum, Federica Sallusto, The Journal of Urology	2001	25
Human Breast Carcinoma Patients Develop Clonable Oncofetal Antigen-Specific Effector and Regulatory T Lymphocytes James W. Rohrer, Adel L. Barsoum, Donna Lynn Dyess, The Journal of Immunology Breast OncologyLymphocyte DevelopmentImmunologyImmune RegulationPathology	1999	25
Differential recognition of murine tumor-associated oncofetal transplantation antigen and individually specific tumor transplantation antigens by syngeneic cloned BALB/c and RFM mouse T cells. Jack Rohrer, Sky Rohrer, Adel L. Barsoum, The Journal of Immunology HistocompatibilityCell TherapyFetal CellsImmunologyPathology	1994	23
Humoral Immune Responses against the Immature Laminin Receptor Protein Show Prognostic Significance in Patients with Chronic Lymphocytic Leukemia Birte Friedrichs, Sandra Siegel, Marita Kloess, The Journal of Immunology	2008	19

Page 1